Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review

Authors

  • Archita Tiwari Faculty of Pharmacy, Khawaja Moinuddin Chishti Language University, Lucknow
  • Arti Verma Department of Pharmaceutics, RGS College of Pharmacy, Itaunja, Lucknow
  • Shrishti Mishra Department of Pharmaceutics,RGS College of Pharmacy, Itaunja, Lucknow
  • Bharat Mishra Institute of Pharmacy, Dr. Shakuntala Misra National Rehabilitation University, Lucknow

DOI:

https://doi.org/10.47957/ijciar.v7i2.170

Keywords:

PCOD, lifestyle changes, metabolic disorder

Abstract

Polycystic Ovarian Disorder (PCOD) is a prevalent endocrine illness in women of reproductive age which is a reproductive and metabolic disorder. It shows hormonal abnormalities in which there is an excessive production of androgens and that is one of the main causes of infertility, diabetes, irregular menstrual periods, hirsutism, hair loss, obesity and acne. One of the main features of PCOD is the presence of cysts on the ovaries, which can affect their ability to release eggs regularly and Anti-Müllerian hormone (AMH) plays an inhibitory role in follicular development and recruitment, contributing to follicular arrest. AMH inhibitory action on FSH-induced aromatase production likely contributes to hyperandrogenism in PCOD. Some factors which can cause of PCOD such as lack of exercise, skipping breakfast, fast food, unbalanced sleep, obesity, genetic, environmental   factors and stress level. Lifestyle and nutrition can affect PCOD development and maintenance in PCOD can be done by lifestyle changes such as diet regulation (in taking of vitamins, antioxidant and Creatine) and exercise, as well as medications to regulate hormones, improve fertility and sleep which play a vital role in PCOD management.

Downloads

Download data is not yet available.

References

El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud GJFip. Poly cystic ovarian syndrome: an updated overview. 2016;7:124. DOI: https://doi.org/10.3389/fphys.2016.00124

Gervásio CG, Bernuci MP, Silva-de-Sá MF, Rosa-e-Silva ACJdSJISRN. The role of androgen hormones in early follicular development. 2014;2014. DOI: https://doi.org/10.1155/2014/818010

Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. 2016;22(6):687-708. DOI: https://doi.org/10.1093/humupd/dmw025

Hafez E, Hafez BJRifa. Folliculogenesis, egg maturation, and ovulation. 2000:68-81. DOI: https://doi.org/10.1002/9781119265306.ch5

KASE NGJD, DISORDERS MOO. Polycystic Ovarian Syndrome.337.

Narayan V. Ayurvedic Management of Polycystic Ovarian Disease with Chandraprabha Vati: Rajiv Gandhi University of Health Sciences (India); 2013.

Koneru A, S PJJoPH. Polycystic ovary syndrome (PCOS) and sexual dysfunctions. 2019;1(2):154-8. DOI: https://doi.org/10.1177/2631831819861471

Wild RAJS. Dyslipidemia in PCOS. 2012;77(4):295-9. DOI: https://doi.org/10.1016/j.steroids.2011.12.002

Lang CJ, Appleton SL, Vakulin A, McEvoy DR, Wittert GA, Martin SA, et al. Obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS) are independently associated with depression in a community based population of Australian men. 2015;191(C19):A3934.

Elsheikh M, Murphy C. Polycystic ovary syndrome: Oxford University Press; 2008. DOI: https://doi.org/10.1093/oso/9780199213689.001.0001

Oduwole OO, Huhtaniemi IT, Misrahi MJIjoms. The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited. 2021;22(23):12735. DOI: https://doi.org/10.3390/ijms222312735

Witchel SFJPE. Hirsutism and polycystic ovary syndrome. 2006:349-72.

Trüeb RM, Trüeb RMJTDHLPGtSMoA, Conditions R. The difficult dermatologic condition. 2015:49-137. DOI: https://doi.org/10.1007/978-3-319-19701-2_4

Zehravi M, Maqbool M, Ara IJIjoam, health. Polycystic ovary syndrome and infertility: an update. 2022;34(2):1-9. DOI: https://doi.org/10.1515/ijamh-2021-0073

Tsilchorozidou T, Overton C, Conway GSJCe. The pathophysiology of polycystic ovary syndrome. 2004;60(1):1-17. DOI: https://doi.org/10.1046/j.1365-2265.2003.01842.x

Zeng X, Xie Y-j, Liu Y-t, Long S-l, Mo Z-cJCca. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. 2020;502:214-21. DOI: https://doi.org/10.1016/j.cca.2019.11.003

Rimon-Dahari N, Yerushalmi-Heinemann L, Alyagor L, Dekel NJMmocdigd. Ovarian folliculogenesis. 2016:167-90. DOI: https://doi.org/10.1007/978-3-319-31973-5_7

Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. 1999;96(15):8573-8. DOI: https://doi.org/10.1073/pnas.96.15.8573

Josso N, Belville C, Di Clemente N, Picard J-YJHru. AMH and AMH receptor defects in persistent Müllerian duct syndrome. 2005;11(4):351-6. DOI: https://doi.org/10.1093/humupd/dmi014

Garg D, Tal RJRbo. The role of AMH in the pathophysiology of polycystic ovarian syndrome. 2016;33(1):15-28. DOI: https://doi.org/10.1016/j.rbmo.2016.04.007

Khan MJ, Ullah A, Basit SJTaocg. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. 2019:249-60. DOI: https://doi.org/10.2147/TACG.S200341

Leistner C, Menke AJHocn. Hypothalamic–pituitary–adrenal axis and stress. 2020;175:55-64. DOI: https://doi.org/10.1016/B978-0-444-64123-6.00004-7

DITZEN B, LOUCKS TL, BERGA SLJIWsH. The role of Stress in Infertility. 2010;4:250. DOI: https://doi.org/10.1093/med/9780195378818.003.0016

Gard T, Noggle JJ, Park CL, Vago DR, Wilson AJFihn. Potential self-regulatory mechanisms of yoga for psychological health. 2014;8:100258. DOI: https://doi.org/10.3389/fnhum.2014.00770

Fujiwara T, Sato N, Awaji H, Nakata RJTOFSJ. Adverse effects of dietary habits on menstrual disorders in young women. 2007;1(1). DOI: https://doi.org/10.2174/1874256400701010024

Akhila G, Shaik A, Kumar RDJIJoRiH, Pharmacy C. Current factors affecting the menstrual cycle. 2020;2(1):18-21. DOI: https://doi.org/10.33974/ijrhcp.v2i1.165

Sanderson JT, Letcher RJ, Heneweer M, Giesy J, van den Berg MJEHP. Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. 2001;109(10):1027-31. DOI: https://doi.org/10.1289/ehp.011091027

Ko KM, Han K, Chung YJ, Yoon K-H, Park YG, Lee S-HJE, et al. Association between body weight changes and menstrual irregularity: the Korea National Health and Nutrition Examination Survey 2010 to 2012. 2017;32(2):248. DOI: https://doi.org/10.3803/EnM.2017.32.2.248

Orio F, Muscogiuri G, Ascione A, Marciano F, Volpe A, La Sala G, et al. Effects of physical exercise on the female reproductive system. 2013;38(3):305-19.

Thom G, Lean MJG. Is there an optimal diet for weight management and metabolic health? 2017;152(7):1739-51. DOI: https://doi.org/10.1053/j.gastro.2017.01.056

Chaudhary SA, Yogesh Manani YM, Archana Pithadiya AP, Pravin Masram PM, Krutika Joshi KJ, Satyavati Rathia SR. Modern life-style: a threat for the fertility. 20151Luciano AA, Lanzone A, Goverde AJJIJoG, Obstetrics. Management of female infertility from hormonal causes. 2013;123:S9-S17. DOI: https://doi.org/10.1016/j.ijgo.2013.09.007

Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, et al. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. 2021;12:741764. DOI: https://doi.org/10.3389/fendo.2021.741764

Gayathri K. A study to assess the effectiveness of lifestyle modification package on knowledge and attitude regarding weight reduction among women with pcos at janet nursing home, Trichy: Our Lady of Health College of Nursing, Thanjavur; 2015.

Hoeger KMJCo, gynecology. Obesity and lifestyle management in polycystic ovary syndrome. 2007;50(1):277-94. DOI: https://doi.org/10.1097/GRF.0b013e31802f54c8

Butt MS, Saleem J, Zakar R, Aiman S, Khan MZ, Fischer FJBPH. Benefits of physical activity on reproductive health functions among polycystic ovarian syndrome women: a systematic review. 2023;23(1):882. DOI: https://doi.org/10.1186/s12889-023-15730-8

Olcese JMJFie. Melatonin and female reproduction: an expanding universe. 2020;11:515354. DOI: https://doi.org/10.3389/fendo.2020.00085

Terzieva DD, Orbetzova MM, Mitkov MD, Mateva NGJFM. Serum melatonin in women with polycystic ovary syndrome. 2013;55(2):10. DOI: https://doi.org/10.2478/folmed-2013-0012

Shrestha A, Dixit A, Zaidi AJJoF, Sciences N. Assessment of lifestyle and diet modification of patients suffering from polycystic ovarian disease (PCOD) in North India. 2019;7(4):60-5. DOI: https://doi.org/10.11648/j.jfns.20190704.12

De Leo V, Musacchio M, Cappelli V, Massaro M, Morgante G, Petraglia FJRB, et al. Genetic, hormonal and metabolic aspects of PCOS: an update. 2016;14(1):1-17. DOI: https://doi.org/10.1186/s12958-016-0173-x

Gottfried S, Hamrick K. Vitamin D and Polycystic Ovary Syndrome (PCOS)| Blog| Metagenics.

Fatahi S, Pezeshki M, Mousavi S, Teymouri A, Rahmani J, Varkaneh HK, et al. Effects of folic acid supplementation on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. 2019;29(5):432-9. DOI: https://doi.org/10.1016/j.numecd.2018.11.006

Fonseca V, Guba SC, Fink LMJEr. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. 1999;20(5):738-59. DOI: https://doi.org/10.1210/edrv.20.5.0381

Sharma Ghimeray P. Impact of Age, Meal, Diet and Digestive Discomfort on B-Vitamin Bioavailability: ResearchSpace@ Auckland; 2021.

Irianto CB, Prasetyadi EGJCDK. Coenzyme Q10 and/or Vitamin E Supplementation for Polycystic Ovarian Syndrome. 2021;48(11):361-4. DOI: https://doi.org/10.55175/cdk.v48i11.150

Begum MS, Areen S. Optimizing Polycystic Ovarian Disorder (PCOD) Treatment with Personalized Lifestyle and Nutrition Strategies. 2023. DOI: https://doi.org/10.46889/JCMR.2023.4306

Sengupta P, Dutta S, Hassan MFJJoIS, Technology. Polycystic ovary syndrome (PCOS) and oxidative stress. 2024;12(3):752-. DOI: https://doi.org/10.62110/sciencein.jist.2024.v12.752

Büyükgebiz A, Böber E, Büyükgebiz BJJoPE, Metabolism. Vitamin A and beta carotene levels in constitutional delay of growth and puberty. 1997;10(1):51-4. DOI: https://doi.org/10.1515/JPEM.1997.10.1.51

Skoracka K, Ratajczak AE, Rychter AM, Dobrowolska A, Krela-Kaźmierczak IJAin. Female fertility and the nutritional approach: the most essential aspects. 2021;12(6):2372-86. DOI: https://doi.org/10.1093/advances/nmab068

Meera B, Muralidharan P, Hari RJJoH, Spices, Plants M. Antioxidant potential of Caesalpenia bonducella seeds in the management of polycystic ovary syndrome (PCOS) using mifepristone induced rats model. 2021;27(2):123-34. DOI: https://doi.org/10.1080/10496475.2020.1795041

Hussain A. To Explore the Insilico Potential of Olea Europaea Fruit for Drug Development in PCOS: CAPITAL UNIVERSITY; 2022.

Raja-Khan N, Stener-Victorin E, Wu X, Legro RSJAJoP-E, Metabolism. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. 2011;301(1):E1-E10. DOI: https://doi.org/10.1152/ajpendo.00667.2010

Huang Y, Zhang XJM. Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome. 2023;102(39):e35403. DOI: https://doi.org/10.1097/MD.0000000000035403

Luo X, Cai W-Y, Ma H-L, Cong J, Chang H, Gao J-S, et al. Associations of serum magnesium with Insulin resistance and testosterone in women with polycystic ovary syndrome. 2021;12:683040. DOI: https://doi.org/10.3389/fendo.2021.683040

Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi AJCdih. Oxidative stress and reactive oxygen species. 2005;149:240-60. DOI: https://doi.org/10.1159/000085686

Hejmej A, Kotula-Balak M, Bilińska BJSCA. Antiandrogenic and estrogenic compounds: effect on development and function of male reproductive system. 2011:57-9. DOI: https://doi.org/10.5772/28538

Luque-Ramírez M, Ortiz-Flores AE, Nattero-Chávez L, Escobar-Morreale HFJEOoDS. A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy. 2020;19(12):1559-76. DOI: https://doi.org/10.1080/14740338.2020.1839409

Vrbikova J, Cibula DJHru. Combined oral contraceptives in the treatment of polycystic ovary syndrome. 2005;11(3):277-91. DOI: https://doi.org/10.1093/humupd/dmi005

Rashidi B, Abediasl J, Tehraninejad E, Rahmanpour H, Sills ESJJoIM. Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebo-controlled clinical trial. 2011;59(6):912-6. DOI: https://doi.org/10.2310/JIM.0b013e31821bfd9c

Mannava LL. A Comparative Study on Ovulation Induction with Clomiphene Citrate Versus Letrozole in Women with Infertility: A Prospective Randomized Trial at Infertility Clinic, KVG Medical College and Hospital Sullia: Rajiv Gandhi University of Health Sciences (India); 2020.

Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli FJCs. Cellular and molecular mechanisms of metformin: an overview. 2012;122(6):253-70. DOI: https://doi.org/10.1042/CS20110386

Somani N, Sawaya MJCDDT. Antiandrogens and Androgen Inhibitors. 2019;4.

Pilutin A, Misiakiewicz-Has K, Kolasa A, Baranowska-Bosiacka I, Marchlewicz M, Wiszniewska BJFHeC. The immunoexpression of androgen receptor, estrogen receptors alpha and beta, vanilloid type 1 receptor and cytochrome p450 aromatase in rats testis chronically treated with letrozole, an aromatase inhibitor. 2014;52(3):206-17. DOI: https://doi.org/10.5603/FHC.2014.0024

Published

27-05-2024

How to Cite

Tiwari, A., Verma, A., Mishra, S., & Mishra, B. (2024). Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review. International Journal of Current Innovations in Advanced Research, 7(2), 1–10. https://doi.org/10.47957/ijciar.v7i2.170

Issue

Section

Review Articles

Citations